✦ LIBER ✦

Long Term Efficacy and Safety of Mipomersen During 4 Years of Treatment in a Cohort of Patients with Heterozygous Familial Hypercholesterolemia and Coronary Artery Disease (CAD)

✍ Scribed by Duell, P. Bart; Rose, J.E.; Selvey, S.; Alam, Shushama; Mittleman, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Safety and Efficacy of Mipomer

✍ P. Barton Duell; Raul D. Santos; Cara East; John R. Guyton; Patrick M. Moriarty; 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 48 KB

Long-term safety and efficacy of high-do

✍ Sanne van Wissen; Tineke J. Smilde; Mieke D. Trip; Anton F.H. Stalenhoef; John J 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Prevalence and predictors of subclinical

✍ Lumby, J.; Moffat, A.; Bates, T.; Watts, G.; Abraham, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The potential of mipomersen, an ApoB syn

✍ Vogt, Anja; Parhofer, Klaus G 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 275 KB

4.P.37 Coronary calcification and regres

✍ Ueda, K.; Higashikata, T.; Noto, M.; Kajinami, K.; Koizumi, J.; Mabuchi, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Th-P16:385 Efficacy and safety of long-t

✍ Chumburidze, Sh.D.; Kipshidze, N.N.; Shelia, G.D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 152 KB